Patient and graft survival of deceased donor transplant in one year’s post kidney transplant Experience of single center, what does need for results to be better than this?

Until this time the best modality for treatment of end stage renal failure (ESRD) is kidney transplantation, but the most important problem with that is shortage of donor. A deceased donor is the main provider of kidney and a relative and unrelative live donor is secondary provider of kidney for transplantation. But in deceased donor in comparing with live donor there is not a time for complete evaluation and almost to be in bad condition for deceased donor so it seems that there will be some difference in deceased and live donor outcome. We investigated patient and graft survival in deceased donor in one year after Transplantation in our center. Material and method: From 2003 until 2018 in our center there were 88 ESRD patients between age of 12 to 67 years 33 females 55males that have been transplanted with deceased donors , donors( between ages 5to 60 years 12 females 35 males) but we just only approached 85 cases of recipients (43 males and 42 females) and investigated for patient and graft survival : all of recipients have been treated with induction of ATG and then triple medicines Sandimune or Tacrolimuse and prednisolone and Imuran Cellcept and operation have been carried out with one team of surgery. Results: 8 cases expired about in first 2 months of operation (8 case in early times) and 77 patients were live in one year (90/58%) and overall 16-allograft loss in one year ,69 allografts survived in one year (81/17%). Conclusion: In our center one-year graft survival was 81/17% and patient survival was 90/58% which results may be comparable with other centers and it seems that the result can be better than this in our center which we will discuss in this paper. *Correspondence to: Afshar Zomorrodi, Professor of urology and kidney transplant surgeon, Head of organ transplantation Department, Imam Reza hospital, Tabriz medical science University, Tabriz -Iran, E-mail: dr_zomorrodi@ yahoo.com